Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jevtana in Temozolomide Refractory Glioblastoma Multiforme
NCT01866449Phase 2Completed
- Sponsor
- Ulm University
- Start
- Oct 2013
- Primary completion
- Dec 2016
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel in glioblastoma multiforme (GBM), sponsored by Ulm University. Started Oct 2013; status: completed.
02
Drugs
cabazitaxel
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT01866449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01866449.